SK bioscience Takes Major Step Forward with IND Submission for 2-Dose Varicella Vaccine Phase 3 Trial SK bioscience has submitted an IND to initiate a Phase 3 trial for its 2-dose varicella vaccine, aligning with global vaccination standards and addressing rising market demand.

SK bioscience Takes Major Step Forward with IND Submission for 2-Dose Varicella Vaccine Phase 3 Trial #South_Korea #Seongnam #SK_bioscience #Varicella_Vaccine #SKYVaricella